Chicago—Like so many other Americans, Inger Damon, MD, PhD, chief of the Poxvirus Section of the Centers for Disease Control and Prevention (CDC) in Atlanta, felt life change on September 11, 2001. "A few hours after the terrorist attacks, I walked over to the office of a colleague and told him that the emphasis in our lab would now change from basic science research on smallpox to diagnosis." Damon, who has been working at the CDC since 1999, is helping the agency and the country gear up for a possible bioterrorism attack.
Lovinger S. Addressing the Unthinkable. JAMA. 2002;288(20):2530. doi:10.1001/jama.288.20.2530-JMN1127-3-1